MONIA BRETT P has a total of 22 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are TRIMED BIOTECH GMBH, JADHAV VASANT and SMITH HOLDINGS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 22 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change mitigation in goods production | |
#5 | Sugars | |
#6 | Enzymes | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Monia Brett P | 22 |
#2 | Freier Susan M | 6 |
#3 | Bhanot Sanjay | 5 |
#4 | Mckay Robert | 4 |
#5 | Cowsert Lex M | 4 |
#6 | Bennett C Frank | 3 |
#7 | Gaarde William A | 3 |
#8 | Dobie Kenneth W | 3 |
#9 | Butler Madeline M | 3 |
#10 | Wyatt Jacqueline R | 2 |
Publication | Filing date | Title |
---|---|---|
US2012184031A1 | Antisense inhibition via rnase h-independent reduction in mrna | |
US2013331434A1 | Methods for modulating factor 12 expression | |
US2010331392A1 | Antidotes to antisense compounds | |
US8778900B2 | Modulation of eIF4E-BP1 expression | |
US2003119769A1 | Antisense oligonucleotide modulation of raf gene expression |